The Zentalis Wee1 inhibitor, ZN-c3, is a highly selective kinase inhibitor that is currently being evaluated in Ph. II clinical trials in adult women with recurrent or persistent uterine serous…
Home > ZN-c3
this content is exclusive to
Premium members
Unlock this content with a Premium membership to read it now.